MSC Therapy: Understanding Mesenchymal Stem Cells and the Evidence

What is MSC therapy?

Mesenchymal stem cells, or MSCs, are a type of adult cell originally identified for their ability to give rise to several tissue types. A foundational 1999 study published in Science demonstrated the multilineage potential of adult human MSCs, showing they could differentiate into lineages such as bone, cartilage, and fat under the right laboratory conditions. That discovery is part of why MSCs became one of the most widely studied cell types in regenerative medicine.

MSC therapy refers broadly to approaches that use these cells in an effort to influence injury, inflammation, or tissue repair. It is important to be clear at the outset: while MSCs have been studied extensively, much of this work remains investigational, and the therapy is not an approved cure for any specific condition. This article is educational and not medical advice.

How MSCs are thought to work

Early excitement around MSCs assumed they would work by engrafting at a site of injury and physically rebuilding damaged tissue. The science has since shifted. An influential 2011 review in Cell Stem Cell described the MSC as an "injury drugstore," proposing that these cells act mainly by secreting bioactive, immunomodulatory factors rather than by becoming new tissue themselves.

This reframing went further in 2017, when researcher Arnold Caplan argued in Stem Cells Translational Medicine that the cells were poorly named. He proposed calling them "Medicinal Signaling Cells," reflecting the view that at clinically relevant doses they signal to surrounding cells and modulate immune activity rather than differentiating into replacement tissue. In other words, the leading mechanistic hypothesis is that MSCs may influence the local environment of an injury, not rebuild it directly.

What the research shows

This is where honesty matters most. The gap between laboratory promise and human results has been significant. A candid 2018 review in Cell Stem Cell examined why much of the preclinical promise around MSCs has not translated into clear clinical benefit, highlighting the real challenges of moving these therapies from the bench to reliable patient outcomes.

One of the most rigorously studied applications is knee osteoarthritis. A 2024 systematic review and meta-analysis published in Osteoarthritis and Cartilage pooled 16 randomized controlled trials covering 807 patients and found little-to-no benefit for pain or function, with the authors grading this as moderate-certainty evidence. That is an important finding: randomized controlled trials and meta-analyses sit near the top of the evidence hierarchy, and this analysis does not support strong claims of benefit for knee osteoarthritis. Across the field, much of the supporting work remains mechanistic, preclinical, or based on smaller or earlier-stage studies.

What MSC therapy is being explored for

Because of their proposed immunomodulatory and signaling properties, MSCs continue to be investigated across a range of inflammatory and degenerative conditions in ongoing research. The interest is real, and the mechanistic rationale is plausible, but interest and rationale are not the same as proven human benefit.

For anyone weighing this option, the most accurate framing is that MSC therapy is an area of active, investigational research with mixed human results to date. It may suit people who are exploring options with clear eyes, who understand the evidence is still developing, and who want to make decisions alongside a qualified physician rather than on the basis of marketing claims. It is not a guaranteed solution, and credible information should always reflect that.

How Strong Craft Regen approaches MSC therapy

Strong Craft Regen is a coordination and education service, not a clinic. We help people understand options like MSC therapy and, where appropriate, coordinate care delivered by licensed physicians at Innovita Clinic in Vilnius, Lithuania. Every clinical decision sits with those physicians, who assess each individual case.

Our role is to make sure you go in informed. That means walking through what the evidence does and does not support, being honest about the investigational nature of MSC therapy, and never overstating what the science shows. If you are curious about whether this area of regenerative medicine is relevant to your situation, you are welcome to book a call so we can talk through your questions and, if it fits, connect you with the physician team for a proper medical assessment.

This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. MSC Therapy is discussed in the context of the published research; inclusion of a study does not imply a guaranteed outcome. Many of these compounds are investigational and not approved for the uses described in all jurisdictions. Any treatment decision should be made with a qualified physician. Individual results vary.